Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 64, Issue 12
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2loxP/loxP Villin-Cre mice
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
GI cancer
Original article
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2
loxP/loxP
Villin-Cre mice
Online download statistics by month:
Online download statistics by month: November 2014 to August 2023
Abstract
Full
Pdf
Nov 2014
176
200
40
Dec 2014
215
173
53
Jan 2015
62
84
34
Feb 2015
28
51
22
Mar 2015
43
49
18
Apr 2015
27
32
28
May 2015
29
38
14
Jun 2015
43
33
14
Jul 2015
16
30
14
Aug 2015
32
21
20
Sep 2015
34
49
22
Oct 2015
21
30
7
Nov 2015
1307
144
109
Dec 2015
680
84
67
Jan 2016
280
42
31
Feb 2016
177
47
37
Mar 2016
111
66
25
Apr 2016
81
27
18
May 2016
75
25
16
Jun 2016
44
64
17
Jul 2016
53
45
18
Aug 2016
47
18
7
Sep 2016
67
44
21
Oct 2016
55
28
10
Nov 2016
41
32
17
Dec 2016
42
72
10
Jan 2017
31
360
7
Feb 2017
6
113
3
Mar 2017
0
27
14
Apr 2017
1
30
6
May 2017
2
53
6
Jun 2017
9
32
7
Jul 2017
27
27
5
Aug 2017
28
28
5
Sep 2017
33
33
8
Oct 2017
34
34
3
Nov 2017
32
32
6
Dec 2017
44
42
8
Jan 2018
50
53
13
Feb 2018
46
47
24
Mar 2018
39
43
5
Apr 2018
45
45
13
May 2018
89
89
18
Jun 2018
57
57
8
Jul 2018
53
51
11
Aug 2018
34
34
8
Sep 2018
41
41
17
Oct 2018
87
64
9
Nov 2018
40
38
7
Dec 2018
33
31
3
Jan 2019
32
26
8
Feb 2019
41
35
437
Mar 2019
28
24
17
Apr 2019
28
25
10
May 2019
23
23
15
Jun 2019
23
21
12
Jul 2019
49
43
14
Aug 2019
59
59
8
Sep 2019
48
39
15
Oct 2019
29
28
11
Nov 2019
32
26
7
Dec 2019
66
64
19
Jan 2020
50
50
11
Feb 2020
59
52
11
Mar 2020
84
66
6
Apr 2020
54
52
75
May 2020
55
47
8
Jun 2020
40
36
12
Jul 2020
25
21
7
Aug 2020
26
15
12
Sep 2020
58
35
16
Oct 2020
47
36
13
Nov 2020
37
35
16
Dec 2020
42
42
13
Jan 2021
39
38
14
Feb 2021
36
30
13
Mar 2021
51
51
10
Apr 2021
62
60
21
May 2021
80
78
15
Jun 2021
57
57
7
Jul 2021
58
59
16
Aug 2021
56
56
12
Sep 2021
61
61
12
Oct 2021
44
34
27
Nov 2021
43
37
30
Dec 2021
26
26
9
Jan 2022
44
41
16
Feb 2022
34
30
17
Mar 2022
37
32
11
Apr 2022
53
52
9
May 2022
64
58
25
Jun 2022
86
79
12
Jul 2022
76
63
20
Aug 2022
52
49
15
Sep 2022
53
49
11
Oct 2022
63
49
18
Nov 2022
38
36
17
Dec 2022
56
36
59
Jan 2023
33
24
10
Feb 2023
75
60
9
Mar 2023
45
27
18
Apr 2023
41
27
11
May 2023
35
28
17
Jun 2023
25
23
2
Jul 2023
31
18
14
Aug 2023
30
27
10
Total
7266
5227
2183
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BSG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?